Registration is required to view this event live or on demand. Please complete the form or login below.

Determining the Impact of New Therapeutic Approaches: Advancing Imaging in Animals

Event Date: Wednesday, December 7, 2011 12:00 noon ET; 9 a.m. PT; 5 p.m. GMT, 6 p.m. CEST

A major advantage of in vivo imaging by fluorescence tomography is that it enables the study of biological targets and pathways in context and in their natural state. Within a preclinical setting, such imaging allows disease states to be observed and measured non-invasively within the whole animal, bridging the gap between drug discovery and human clinical trials. Specifically, the Imaging agents developed in the laboratory for use in fluorescence molecular tomography, are now even being translated into the clinic for human diagnostic applications. Similarly, disease-specific fluorescence markers are finding their way back into basic research in high content screening applications. In this third and final webinar in our cell to well to animal series, we will survey the in vivo imaging landscape and follow the flow of technologies and methodologies between lab and clinic.

During the webinar, our expert panelists will:

Discuss the most important considerations when performing in vivo imaging
Describe how in vivo imaging has been applied in their research
Provide examples of the impact new technologies are having on fundamental research and drug development
Answer your questions live!

If you have already registered for this webinar, you may sign in here.

First Name

Last Name

Job Title

Company

Street Address Line 1

Street Address Line 2

City

US State or Canadian Province

Foreign State

US Zip or Postal Code Please enter NA if not applicable

Foreign Code

Country

Work Email Address

Work Phone

Work Sector

2. What optical imaging system(s) do you use? Check all that apply

Fluorescence (please specify below)

Bioluminescence (please specify below)

Other (such as PET, X-Ray, MR)

Please specify the name of the system you use:

3. What kind of imaging agents or reagents do you use in your work? Check all that apply

PerkinElmer or Visen agents/dyes

LI-COR

Life Technologies

Caliper

Carestream

I make my own

I did use agents/dyes in the past, but not now

I have never used in vivo agents or dyes

Other

If you checked Other above, please specify:

I understand that by registering to watch this webinar I am agreeing to receive occasional e-mail from Science/AAAS and the sponsor of this webinar, about their respective programs and products. The webcast sponsor and Science/AAAS agree not to rent, sell, exchange, or give your information to any third party without permission.

Denotes required

1. What disease area are you studying using preclinical imaging? Check all that apply

2. What optical imaging system(s) do you use? Check all that apply

3. What kind of imaging agents or reagents do you use in your work? Check all that apply